London Councils have announced they will add an additional 4,000 new places to the NHS England PrEP trial after it was reported many clinics had reached capacity and were turning gay and bisexual men away.
When taken daily, PrEP (otherwise known as its brand name Truvada) drastically reduces the chances of HIV infection.
Councillor Ray Puddifoot, London Councils Executive Member for Health & Care saidin response to the 4,000 additional new trial places: “We’ve played a key role in the success of the trial so far, rolling out the programme in sexual health clinics across the capital to ensure thousands of Londoners receive PrEP.
“We’re pleased to announce that boroughs will provide these additional places on the PrEP Impact Trial. Looking to the future, we’re keen for national partners in the government and NHS to confirm funding arrangements for PrEP provision.
“While extra places on the PrEP Impact Trial represent a step forward, we ultimately want to see NHS-funded PrEP available to everyone at high risk of HIV exposure – as is the case in Scotland and Wales.”
“This is a welcome step in the right direction that will provide some relief to those in the capital who have been denied access to the trial,” said Debbie Laycock, head of policy with the Terrence Higgins Trust.
“We welcome the acknowledgement by London Councils that PrEP must be available to everyone at high risk of HIV exposure and as such withholding access is simply not an option.”